{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:14:02Z","timestamp":1790356442281,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010201","name":"U.S. Army Medical Research Institute of Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010201","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.antiviral.2020.104854","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T21:39:41Z","timestamp":1593639581000},"page":"104854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of type I interferon"],"prefix":"10.1016","volume":"181","author":[{"given":"Kamal U.","family":"Saikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Morazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5232-8110","authenticated-orcid":false,"given":"Ashley E.","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Bakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104854_bib1","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1128\/JVI.02514-07","article-title":"Structural and nonstructural protein genome regions of Eastern Equine Encephalitis Virus are determinants of interferon sensitivity and murine virulence","volume":"82","author":"Aguilar","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cbdd.12477","article-title":"Structure-based design and synthesis of a small molecule that exhibits anti-inflammatory activity by inhibition of MyD88- mediated signaling to bacterial toxin exposure","volume":"86","author":"Alam","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.antiviral.2020.104854_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086745","article-title":"The role of IKK\u03b2 in Venezuelan equine encephalitis virus infection","volume":"9","author":"Amaya","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104854_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.crvi.2004.04.002","article-title":"Functions of toll-like receptors: lessons from KO mice","volume":"327","author":"Akira","year":"2004","journal-title":"C R Biol."},{"key":"10.1016\/j.antiviral.2020.104854_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jir.2013.0035","article-title":"Ebola virus-like particles stimulate Type I interferons and pro-inflammatory cytokine expression through the toll-like receptors and interferon signaling pathways","volume":"34","author":"Ayithan","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2020.104854_bib7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","article-title":"The interferons. Mechanisms of action and clinical applications","volume":"266","author":"Baron","year":"1991","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.antiviral.2020.104854_bib8","first-page":"819","article-title":"Interferons as therapeutic agents for infectious diseases","volume":"25","author":"Bergman","year":"2011","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.antiviral.2020.104854_bib9","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","article-title":"A mouse model for Chikungunya: young age and in-efficient type-I interferon signaling at risk factor for severe disease","volume":"4","author":"Couderc","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104854_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004213","article-title":"Discovery of a novel Compound with Venezuelan Equine Encephalitis Virus activity that targets the nonstructural- protein 2","volume":"10","author":"Chung","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104854_bib11","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1371\/journal.ppat.0030106","article-title":"Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms","volume":"3","author":"Daffis","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104854_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005096","article-title":"Knocking on closed doors: host interferons dynamically regulate blood-brain barrier function during viral infections of the central nervous system","volume":"11","author":"Daniels","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104854_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01476-14","article-title":"Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals","volume":"5","author":"Daniels","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2020.104854_bib14","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1073\/pnas.0510802103","article-title":"MyD88- dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll\/IL-1 receptor domain\/BB-loop mimetics","volume":"103","author":"Davis","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104854_bib15","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1128\/JVI.74.7.3404-3409.2000","article-title":"Impaired antiviral response and alpha\/beta interferon induction in mice lacking beta interferon","volume":"74","author":"Deonarain","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib16","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.4049\/jimmunol.0800596","article-title":"Local type I IFN receptor signaling protects against virus spread within the central nervous system","volume":"182","author":"Detje","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2020.104854_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"Durbin","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104854_bib18","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.celrep.2016.01.049","article-title":"Differential regulation of interferon responses by ebola and Marburg virus VP35 proteins","volume":"14","author":"Edwards","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2020.104854_bib19","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.20031023","article-title":"LPS-TLR4 signaling to IRF-3\/7 and NF-kappa B involves the toll adapters TRAM and TRIF","volume":"198","author":"Fitzgerald","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2020.104854_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ni921","article-title":"IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway","volume":"4","author":"Fitzgerald","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2020.104854_bib21","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1099\/vir.0.83191-0","article-title":"The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in external tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons","volume":"88","author":"Fragkoudis","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib22","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1128\/JVI.07223-11","article-title":"Early events in Alphavirus replication determine the outcome of infection","volume":"86","author":"Frolov","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib23","first-page":"139","article-title":"Persistent infection and suppression of host response by alphaviruses","volume":"18","author":"Frolov","year":"2004","journal-title":"Arch. Virol. Suppl."},{"key":"10.1016\/j.antiviral.2020.104854_bib24","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/CIRCULATIONAHA.105.536433","article-title":"Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3 induced myocarditis and influences type I interferon production","volume":"112","author":"Fuse","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.antiviral.2020.104854_bib25","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1128\/JVI.72.11.8550-8558.1998","article-title":"The role of interferon in influenza virus tissue tropism","volume":"72","author":"Garc\u00eda-Sastre","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.virol.2009.05.030","article-title":"Type I Interferon induction is correlated with attenuation of a South American eastern encephalitis virus strain in mice","volume":"390","author":"Gardner","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104854_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/110.1.80","article-title":"The comparative pathology of experimental Venezuelan equine encephalomyelitis infection in different animal hosts","volume":"110","author":"Gleiser","year":"1962","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104854_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nri1105","article-title":"Immune responses to RNA-virus infections of the CNS","volume":"3","author":"Griffin","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2020.104854_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/viro.1999.9662","article-title":"Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection","volume":"257","author":"Grieder","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104854_bib30","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/intimm\/dxh318","article-title":"Regulation of the type I IFN induction: a current view","volume":"17","author":"Honda","year":"2005","journal-title":"Int. Immunol."},{"issue":"2005","key":"10.1016\/j.antiviral.2020.104854_bib31","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-1 interferon-dependent immune responses","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104854_bib32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nri1900","article-title":"IRFs: master regulators of signaling by Toll-like receptors and cytosolic pattern-recognition receptors","volume":"6","author":"Honda","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2020.104854_bib33","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.4049\/jimmunol.1500079","article-title":"TLR and RLR signaling are reprogrammed in opposite directions after detection of viral infection","volume":"195","author":"Hotz","year":"2015","journal-title":"J. Immunol."},{"issue":"Suppl. l","key":"10.1016\/j.antiviral.2020.104854_bib34","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1086\/520611","article-title":"Cytokine and chemokine expression in humans infected with Sudan Ebola virus","volume":"196","author":"Hutchinson","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104854_bib35","first-page":"S1","article-title":"Control of nipah virus infection in mice by the host adaptors mitrochondrial antiviral signaling protein (MAVS) and myeloid differentiation primary response 88 (MyD88)","author":"Iampietro","year":"2019","journal-title":"J. Infect. Dis. Suppl."},{"key":"10.1016\/j.antiviral.2020.104854_bib36","doi-asserted-by":"crossref","first-page":"42715","DOI":"10.1074\/jbc.M111.293969","article-title":"MyD88 interacts with interferon regulatory factor (IRF) 3 and IRF7 in Atlantic salmon (Salmon salar): transgenic SsMyD88 modulates the IRF-induced type I interferon response and accumulates in aggresomes","volume":"286","author":"Iliev","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104854_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2020.104854_bib38","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/514310","article-title":"Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections","volume":"179","author":"Jahrling","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104854_bib39","doi-asserted-by":"crossref","first-page":"290ra89","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity","volume":"7","author":"Johansen","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2020.104854_bib40","first-page":"3988","article-title":"MyD88 functions as a negative regulator of TLR3\/TRIF induced corneal inflammation by inhibiting activation of c-Jun N-terminal kinase","volume":"278","author":"Johnson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104854_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.antiviral.2008.07.002","article-title":"Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine","volume":"80","author":"Julander","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104854_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2008.01.007","article-title":"C3H\/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection","volume":"78","author":"Julander","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104854_bib43","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2165\/00003495-200868090-00006","article-title":"Peginterferon-alpha-2a (40 kD) plus ribavirin: a review of its use in the management of chronic hepatitis C mono-infection","volume":"68","author":"Keam","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2020.104854_bib44","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.0901140","article-title":"MyD88 adaptor like is not essential for TLR2 signaling and inhibits signaling by TLR3","volume":"183","author":"Kenny","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2020.104854_bib45","doi-asserted-by":"crossref","first-page":"31385","DOI":"10.1074\/jbc.M110.204982","article-title":"A small molecule that mimics the BB-loop in the Toll\/IL-1 receptor domain of MyD88 attenuates staphylococcal enterotoxin B induced pro-inflammatory cytokine production and toxicity in mice","volume":"286","author":"Kissner","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104854_bib46","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2020.104854_bib47","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1084\/jem.189.4.663","article-title":"Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo","volume":"189","author":"Leib","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2020.104854_bib48","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/MCB.18.5.2986","article-title":"Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome mediated degradation","volume":"18","author":"Lin","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2020.104854_bib49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4269\/ajtmh.2001.64.49","article-title":"Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice","volume":"64","author":"Ludwig","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2020.104854_bib50","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1128\/JVI.74.11.5006-5015.2000","article-title":"Pegylated alpha interferon is an effective treatment for virulent Venezuelan equine encephalitis virus and has profound effects on the host immune response to infection","volume":"74","author":"Lukaszewski","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2018.07.005","article-title":"Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses","volume":"157","author":"Lundberg","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104854_bib52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2014.10.002","article-title":"Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication","volume":"112","author":"Madsen","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104854_bib53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0042-6822(03)00233-2","article-title":"Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection","volume":"312","author":"Mahanty","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104854_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(99)00262-0","article-title":"Interferon regulatory factors: the next generation","volume":"237","author":"Mamane","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.antiviral.2020.104854_bib55","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cid\/ciw334","article-title":"Kinetic analysis of biomarkers in a cohort of US patients with ebola virus disease","volume":"63","author":"McElroy","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104854_bib58","doi-asserted-by":"crossref","first-page":"19884","DOI":"10.1073\/pnas.1320145110","article-title":"Beneficial innate signaling interference for antibacterial responses by a toll-like receptor-mediated enhancement of the MKP-IRF3 axis","volume":"110","author":"Negishi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104854_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1359-6101(97)00019-1","article-title":"The growing family of interferon regulatory factors","volume":"8","author":"Nguyen","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.antiviral.2020.104854_bib60","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.4049\/jimmunol.162.7.4184","article-title":"Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis","volume":"162","author":"Noisakran","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2020.104854_bib61","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1128\/JVI.00262-16","article-title":"HIV-1 tat protein activates both the MyD88 and TRIF pathways to induce tumor necrosis factor Alpha and interleukin-10 in human monocytes","volume":"90","author":"Plan\u00e8s","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib62","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1128\/JVI.74.7.3366-3378.2000","article-title":"Alpha\/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism","volume":"74","author":"Ryman","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib63","author":"Saikh","year":"2017"},{"key":"10.1016\/j.antiviral.2020.104854_bib64","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1084\/jem.20081210","article-title":"Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity","volume":"205","author":"Saito","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2020.104854_bib65","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1099\/vir.0.010280-0","article-title":"Oligonucleotide array analysis of Toll-like receptors and associated signaling genes in Venezuelan equine encephalitis virus-infected mouse brain","volume":"90","author":"Sharma","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib66","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/eji.201040547","article-title":"TLR3-mediated IFN-\u03b2 gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like","volume":"40","author":"Siednienko","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2020.104854_bib67","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.4049\/jimmunol.1003093","article-title":"Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-\u03b2 and RANTES production","volume":"186","author":"Siednienko","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2020.104854_bib68","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/HYPERTENSIONAHA.115.06011","article-title":"Dual activation of TRIF and MyD88 adaptor proteins by angiotensin II evokes opposing effects on pressure, cardiac hypertrophy, and inflammatory gene expression","volume":"66","author":"Singh","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.antiviral.2020.104854_bib69","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/infdis\/jis921","article-title":"Interferon-\u03b2 therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever","volume":"208","author":"Smith","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104854_bib70","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1128\/JVI.72.12.10286-10291.1998","article-title":"Resistance to alpha\/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins","volume":"72","author":"Spotts","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib71","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jviromet.2013.06.007","article-title":"Validation of a cell-based ELISA as a screening tool identifying anti-alphavirus small-molecule inhibitors","volume":"193","author":"Spurgers","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2020.104854_bib72","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/030098589803500508","article-title":"Comparative Neuro-virulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H\/HeN and BALB\/c mice","volume":"35","author":"Steele","year":"1998","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.antiviral.2020.104854_bib73","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2020.104854_bib74","first-page":"4095","article-title":"Natural killer cell mediated pathogenesis determines outcome of central nervous system infection with Venezuelan Equine Encephalitis Virus in C3H\/HeN mice","volume":"30","author":"Taylor","year":"2012"},{"key":"10.1016\/j.antiviral.2020.104854_bib75","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1995.tb00090.x","article-title":"Immune defense in mice lacking type I and\/or type II interferon receptors","volume":"148","author":"Van den Broek","year":"1995","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2020.104854_bib76","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal Zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2020.104854_bib77","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1128\/JVI.75.8.3706-3718.2001","article-title":"Role of alpha\/beta interferon in venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5\u2019 untranslated region","volume":"75","author":"White","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib78","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02246-17","article-title":"RIG-I-Like receptor and toll-like receptor signaling pathways cause aberrant production of inflammatory cytokines\/chemokines in a severe fever with Thrombocytopenia Syndrome virus infection mouse model","volume":"92","author":"Yamada","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104854_bib79","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4049\/jimmunol.160.6.2932","article-title":"Antiviral activities of individual murine IFN alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalo virus replication","volume":"160","author":"Yeow","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2020.104854_bib80","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000495172","article-title":"Type III Interferons in viral infection and antiviral immunity","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.antiviral.2020.104854_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112918","article-title":"Poly (I:C) induces antiviral immune responses in Japanese flounder (Paralichthys olivaceus) that require TLR3 and MDA5 and is negatively regulated by MyD88","volume":"9","author":"Zhou","year":"2014","journal-title":"PloS One"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:18Z","timestamp":1759062678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220302680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":78,"alternative-id":["S0166354220302680"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104854","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of type I interferon","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104854"}}